Biology & Treatments for Compulsive Behaviors & Binge Eating | Dr. Casey Halpern

Episode Summary

Executive Summary: Andrew Huberman and neurosurgeon Casey Halpern discuss how deep brain stimulation, ablation, and emerging non-invasive methods can modulate brain circuits underlying compulsive eating, OCD, addiction, tremor, Parkinson’s, and dystonia. The episode emphasizes nucleus accumbens and frontal-striatal circuits, responsive stimulation timed to craving signals, and the promise—and limits—of current psychiatric neurosurgery.

Main Topics: Neurosurgery as circuit-based brain intervention (Priority: 5/5): Halpern explains that modern functional neurosurgery is less about structural repair and more about precisely modulating neural circuits with electrodes, stimulation, and ablation. He distinguishes this from broader neurosurgical work like tumor removal and spine surgery. OCD, compulsivity, and shared reward-control circuitry (Priority: 5/5): The conversation frames OCD as a disorder of dysregulated cortical-subcortical control, involving orbitofrontal/prefrontal cortex and basal ganglia/ventral striatum. Halpern argues that compulsive behaviors across OCD, addiction, and eating disorders share a common 'urge despite risk' feature. Nucleus accumbens and loss-of-control eating (Priority: 5/5): Halpern describes his Nature Medicine work using responsive deep brain stimulation in the nucleus accumbens to treat loss-of-control eating, aiming to detect craving-related neural signals and interrupt them with brief stimulation. Binge eating disorder, obesity, and anorexia as related but distinct conditions (Priority: 4/5): The episode explores how obesity, binge eating disorder, and anorexia can all involve maladaptive control over eating, but differ in phenotype, severity, and underlying drivers. Halpern argues that some obesity cases are driven by binge/loss-of-control eating, while anorexia may involve opposite behavioral expression within overlapping circuits. Non-invasive neuromodulation: TMS and focused ultrasound (Priority: 4/5): Huberman and Halpern review transcranial magnetic stimulation and MRI-guided focused ultrasound as promising but still limited tools. Halpern stresses that better disease-specific targets are needed before these methods can reliably treat psychiatric and eating disorders. Real-time biomarkers, mood provocation, and responsive therapy (Priority: 4/5): Halpern describes using intraoperative recordings, mood provocation, eye tracking, and connectomics to identify symptom-linked neural signatures. He argues that episodic, responsive stimulation may outperform continuous stimulation for intermittent compulsive states. Physician self-regulation, training, and hand protection (Priority: 2/5): The discussion closes with the demands of neurosurgical training, the importance of calmness and precision, and how exercise, meditation, and posture/strength training help surgeons maintain performance and protect their hands.

Key Arguments: Compulsive disorders are best understood as circuit disorders, not just neurotransmitter imbalances; precise brain targeting may outperform broad pharmacology for severe cases. The nucleus accumbens is a key hub for reward-seeking and compulsive behavior, making it a rational target for binge eating, OCD, addiction, and possibly anorexia. Responsive, intermittent stimulation timed to detected craving signals may be more durable than continuous stimulation for episodic disorders like binge eating. OCD, addiction, binge eating, and some forms of obesity share a common 'urge despite risk' phenotype, even if they differ clinically. Current treatments for OCD and eating disorders help many patients, but a substantial refractory subgroup remains, motivating neurosurgical research. Non-invasive methods like TMS and focused ultrasound are promising, but their effectiveness depends on better circuit mapping and target selection. Awareness of internal states and early detection of pre-binge or pre-impulse states may be a powerful near-term tool, even before highly specific interventions are available. Animal models can inform mechanisms, but human studies are essential for complex psychiatric conditions because these disorders are deeply shaped by human cognition and society.

Data Points: Deep brain stimulation surgeries performed worldwide: about 200,000 - Halpern notes this scale to emphasize that neurosurgery cannot solve population-level psychiatric disease alone. U.S. population with obesity: about 35% - Used to frame obesity as a major public health problem. Estimated prevalence of binge eating disorder: 3% to 5% - Halpern cites current literature estimates and suggests it may be underdiagnosed in obesity. Obesity cases linked to addictive/binge tendencies: about 20% - Halpern cites mentor Tom Wadden’s estimate that a subset of obesity is driven by binge/addictive eating behavior. Responder rate for OCD surgery: about 50% - Halpern says current surgical outcomes for severe OCD are meaningful but not optimal. Size of nucleus accumbens: almost 1 centimeter - He contrasts this with the millimeter-scale precision needed for targeting subregions. Typical target size in functional neurosurgery: 3 to 4 millimeters - Used to explain why small deviations can change outcomes dramatically. Electrode precision on intraoperative imaging: about 0.5 millimeters of error - Halpern describes modern intraoperative CAT scan confirmation of electrode placement. Stimulation duration for responsive therapy: 5 to 10 seconds - Brief stimulation is used to disrupt craving-related signaling rather than continuously stimulate. Frequency of severe binge episodes: about once a day - Halpern explains that severe binge eating disorder often involves one binge per day, though loss-of-control eating can occur more often. Frequency of moderate binge eating: 3 to 4 times a week - He distinguishes moderate from severe binge eating disorder. Loss-of-control eating frequency in studied patients: 20 to 30 times a week - Used to clarify that loss-of-control episodes are more frequent than formal binges. Age-related prevalence note: essential tremor is 10 times as common as Parkinson’s - Halpern highlights essential tremor as a common but under-recognized disorder. Medication consumption statistic: 75% of antidepressant and anti-anxiety medication in the world is consumed in the United States - Huberman cites this to underscore the scale of pharmacologic treatment use in the U.S.

Pivotal Quotes: "We have to get in the brain before we get out of it." — Casey Halpern: Halpern summarizes his view that invasive human circuit mapping is necessary before non-invasive therapies can become precise and effective. "The therapy is delivering electrical stimulation through the tip of that wire... like I have to implant a tool to deliver you a medication. But that medication is going to be in the form of electricity." — Casey Halpern: He explains how deep brain stimulation works as a circuit-based therapy rather than a structural operation. "If we can improve awareness, we can improve outcomes." — Casey Halpern: He argues that patient awareness of cravings, urges, and pre-episode states is clinically valuable, especially for compulsive disorders.

Implications: The episode suggests psychiatry is moving toward circuit-specific, symptom-timed interventions. For patients, awareness and early detection matter now; for the field, human brain mapping, responsive DBS, TMS, and focused ultrasound may reshape treatment of compulsive and movement disorders.